Global Targeted Protein Degradation Drug Market Growth (Status and Outlook) 2026-2032
The global Targeted Protein Degradation Drug market size is predicted to grow from US$ 325 million in 2025 to US$ 658 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.
From an industry chain perspective, targeted protein degradation sits within the advanced biopharmaceutical innovation ecosystem, with upstream activities centered on drug discovery inputs such as target identification platforms, structural biology, ligand screening technologies, E3 ligase libraries, chemical building blocks, and enabling tools provided by CROs, reagent suppliers, and computational biology firms. The development stage is driven by biotech and pharmaceutical companies leveraging medicinal chemistry, protein engineering, and translational research capabilities to design degrader molecules and advance them through preclinical and clinical pipelines. Downstream, the outputs are therapeutic candidates applied across oncology, neurodegenerative diseases, and other protein-driven disorders, ultimately reaching hospitals and patients through established pharmaceutical commercialization channels. Demand is closely tied to the need for novel mechanisms to address previously ?undruggable? targets, positioning targeted protein degradation as a high-value, innovation-driven segment within the broader drug development landscape.
From an industry chain perspective, targeted protein degradation sits within the advanced biopharmaceutical innovation ecosystem, with upstream activities centered on drug discovery inputs such as target identification platforms, structural biology, ligand screening technologies, E3 ligase libraries, chemical building blocks, and enabling tools provided by CROs, reagent suppliers, and computational biology firms. The development stage is driven by biotech and pharmaceutical companies leveraging medicinal chemistry, protein engineering, and translational research capabilities to design degrader molecules and advance them through preclinical and clinical pipelines. Downstream, the outputs are therapeutic candidates applied across oncology, neurodegenerative diseases, and other protein-driven disorders, ultimately reaching hospitals and patients through established pharmaceutical commercialization channels. Demand is closely tied to the need for novel mechanisms to address previously ?undruggable? targets, positioning targeted protein degradation as a high-value, innovation-driven segment within the broader drug development landscape.
From a market perspective, targeted protein degradation represents a high-growth, innovation-driven segment of the biopharmaceutical industry, fueled by its ability to address previously undruggable targets and deliver differentiated therapeutic mechanisms. The field is led by PROTACs and molecular glues, which have advanced into clinical stages, while next-generation platforms such as lysosome- and autophagy-based degraders are expanding the addressable target space. Strong interest from major pharmaceutical companies?through partnerships, licensing, and acquisitions?continues to validate the technology and accelerate pipeline development. At the same time, the market remains early-stage and high-risk, with challenges in drug delivery, selectivity, safety, and clinical validation still to be resolved. Overall, the industry exhibits characteristics of a platform-driven biotech market with significant long-term upside, increasing capital inflow, and the potential to reshape drug discovery paradigms over the next decade.
LPI (LP Information)' newest research report, the ?Targeted Protein Degradation Drug Industry Forecast? looks at past sales and reviews total world Targeted Protein Degradation Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Protein Degradation Drug sales for 2026 through 2032. With Targeted Protein Degradation Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Protein Degradation Drug industry.
This Insight Report provides a comprehensive analysis of the global Targeted Protein Degradation Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Protein Degradation Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Targeted Protein Degradation Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Protein Degradation Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Protein Degradation Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Protein Degradation Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
From an industry chain perspective, targeted protein degradation sits within the advanced biopharmaceutical innovation ecosystem, with upstream activities centered on drug discovery inputs such as target identification platforms, structural biology, ligand screening technologies, E3 ligase libraries, chemical building blocks, and enabling tools provided by CROs, reagent suppliers, and computational biology firms. The development stage is driven by biotech and pharmaceutical companies leveraging medicinal chemistry, protein engineering, and translational research capabilities to design degrader molecules and advance them through preclinical and clinical pipelines. Downstream, the outputs are therapeutic candidates applied across oncology, neurodegenerative diseases, and other protein-driven disorders, ultimately reaching hospitals and patients through established pharmaceutical commercialization channels. Demand is closely tied to the need for novel mechanisms to address previously ?undruggable? targets, positioning targeted protein degradation as a high-value, innovation-driven segment within the broader drug development landscape.
From an industry chain perspective, targeted protein degradation sits within the advanced biopharmaceutical innovation ecosystem, with upstream activities centered on drug discovery inputs such as target identification platforms, structural biology, ligand screening technologies, E3 ligase libraries, chemical building blocks, and enabling tools provided by CROs, reagent suppliers, and computational biology firms. The development stage is driven by biotech and pharmaceutical companies leveraging medicinal chemistry, protein engineering, and translational research capabilities to design degrader molecules and advance them through preclinical and clinical pipelines. Downstream, the outputs are therapeutic candidates applied across oncology, neurodegenerative diseases, and other protein-driven disorders, ultimately reaching hospitals and patients through established pharmaceutical commercialization channels. Demand is closely tied to the need for novel mechanisms to address previously ?undruggable? targets, positioning targeted protein degradation as a high-value, innovation-driven segment within the broader drug development landscape.
From a market perspective, targeted protein degradation represents a high-growth, innovation-driven segment of the biopharmaceutical industry, fueled by its ability to address previously undruggable targets and deliver differentiated therapeutic mechanisms. The field is led by PROTACs and molecular glues, which have advanced into clinical stages, while next-generation platforms such as lysosome- and autophagy-based degraders are expanding the addressable target space. Strong interest from major pharmaceutical companies?through partnerships, licensing, and acquisitions?continues to validate the technology and accelerate pipeline development. At the same time, the market remains early-stage and high-risk, with challenges in drug delivery, selectivity, safety, and clinical validation still to be resolved. Overall, the industry exhibits characteristics of a platform-driven biotech market with significant long-term upside, increasing capital inflow, and the potential to reshape drug discovery paradigms over the next decade.
LPI (LP Information)' newest research report, the ?Targeted Protein Degradation Drug Industry Forecast? looks at past sales and reviews total world Targeted Protein Degradation Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Protein Degradation Drug sales for 2026 through 2032. With Targeted Protein Degradation Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Protein Degradation Drug industry.
This Insight Report provides a comprehensive analysis of the global Targeted Protein Degradation Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Protein Degradation Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Targeted Protein Degradation Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Protein Degradation Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Protein Degradation Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Protein Degradation Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- PROTAC
- Molecular Glues
- Other Ubiquitin-Proteasome System Technologies
- Lysosomal System Technologies
- Proteasome-mediated Degradation
- Lysosome-mediated Degradation
- Autophagy-mediated Degradation
- Small-molecule Degraders
- Biologics-based Degraders
- Oligonucleotide / RNA-targeting Degraders
- Prostate Cancer
- Breast Cancer
- Lymphoma
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Arvinas
- Kymera Therapeutics
- Dialectic Therapeutics
- Bristol-Myers Squibb
- Nurix
- Cullgen
- C4 Therapeutics
- Foghorn
- Novartis
- Pfizer
- MSD
- Origami Therapeutics
- NEOsphere Biotechnologies
- Dunad Therapeutics
- Entact Bio
- Proxygen
- Monte Rosa Therapeutics
- Treeline Biosciences
- Ubiquigent
- Kangpu Biopharmaceuticals
- Ranok Therapeutics
- Accutar Biotech
- BeiGene
- Hinova Pharma
- Haisco Pharmaceutical
- CTTQ
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Protein Degradation Drug Market Size (2021-2032)
2.1.2 Targeted Protein Degradation Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Targeted Protein Degradation Drug by Country/Region (2021, 2025 & 2032)
2.2 Targeted Protein Degradation Drug Segment by Type
2.2.1 PROTAC
2.2.2 Molecular Glues
2.2.3 Other Ubiquitin-Proteasome System Technologies
2.2.4 Lysosomal System Technologies
2.2.5 Targeted Protein Degradation Drug Market Size by Type
2.2.5.1 Targeted Protein Degradation Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
2.3 Targeted Protein Degradation Drug Segment by Degradation Pathway
2.3.1 Proteasome-mediated Degradation
2.3.2 Lysosome-mediated Degradation
2.3.3 Autophagy-mediated Degradation
2.3.4 Targeted Protein Degradation Drug Market Size by Degradation Pathway
2.3.4.1 Targeted Protein Degradation Drug Market Size CAGR by Degradation Pathway (2021 VS 2025 VS 2032)
2.3.4.2 Global Targeted Protein Degradation Drug Market Size Market Share by Degradation Pathway (2021-2026)
2.4 Targeted Protein Degradation Drug Segment by Molecular Structure
2.4.1 Small-molecule Degraders
2.4.2 Biologics-based Degraders
2.4.3 Oligonucleotide / RNA-targeting Degraders
2.4.4 Targeted Protein Degradation Drug Market Size by Molecular Structure
2.4.4.1 Targeted Protein Degradation Drug Market Size CAGR by Molecular Structure (2021 VS 2025 VS 2032)
2.4.4.2 Global Targeted Protein Degradation Drug Market Size Market Share by Molecular Structure (2021-2026)
2.5 Targeted Protein Degradation Drug Segment by Application
2.5.1 Prostate Cancer
2.5.2 Breast Cancer
2.5.3 Lymphoma
2.5.4 Others
2.5.5 Targeted Protein Degradation Drug Market Size by Application
2.5.5.1 Targeted Protein Degradation Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
3 TARGETED PROTEIN DEGRADATION DRUG MARKET SIZE BY PLAYER
3.1 Targeted Protein Degradation Drug Market Size Market Share by Player
3.1.1 Global Targeted Protein Degradation Drug Revenue by Player (2021-2026)
3.1.2 Global Targeted Protein Degradation Drug Revenue Market Share by Player (2021-2026)
3.2 Global Targeted Protein Degradation Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED PROTEIN DEGRADATION DRUG BY REGION
4.1 Targeted Protein Degradation Drug Market Size by Region (2021-2026)
4.2 Global Targeted Protein Degradation Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Targeted Protein Degradation Drug Market Size Growth (2021-2026)
4.4 APAC Targeted Protein Degradation Drug Market Size Growth (2021-2026)
4.5 Europe Targeted Protein Degradation Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Targeted Protein Degradation Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Targeted Protein Degradation Drug Market Size by Country (2021-2026)
5.2 Americas Targeted Protein Degradation Drug Market Size by Type (2021-2026)
5.3 Americas Targeted Protein Degradation Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Protein Degradation Drug Market Size by Region (2021-2026)
6.2 APAC Targeted Protein Degradation Drug Market Size by Type (2021-2026)
6.3 APAC Targeted Protein Degradation Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Protein Degradation Drug Market Size by Country (2021-2026)
7.2 Europe Targeted Protein Degradation Drug Market Size by Type (2021-2026)
7.3 Europe Targeted Protein Degradation Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Protein Degradation Drug by Region (2021-2026)
8.2 Middle East & Africa Targeted Protein Degradation Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED PROTEIN DEGRADATION DRUG MARKET FORECAST
10.1 Global Targeted Protein Degradation Drug Forecast by Region (2027-2032)
10.1.1 Global Targeted Protein Degradation Drug Forecast by Region (2027-2032)
10.1.2 Americas Targeted Protein Degradation Drug Forecast
10.1.3 APAC Targeted Protein Degradation Drug Forecast
10.1.4 Europe Targeted Protein Degradation Drug Forecast
10.1.5 Middle East & Africa Targeted Protein Degradation Drug Forecast
10.2 Americas Targeted Protein Degradation Drug Forecast by Country (2027-2032)
10.2.1 United States Market Targeted Protein Degradation Drug Forecast
10.2.2 Canada Market Targeted Protein Degradation Drug Forecast
10.2.3 Mexico Market Targeted Protein Degradation Drug Forecast
10.2.4 Brazil Market Targeted Protein Degradation Drug Forecast
10.3 APAC Targeted Protein Degradation Drug Forecast by Region (2027-2032)
10.3.1 China Targeted Protein Degradation Drug Market Forecast
10.3.2 Japan Market Targeted Protein Degradation Drug Forecast
10.3.3 Korea Market Targeted Protein Degradation Drug Forecast
10.3.4 Southeast Asia Market Targeted Protein Degradation Drug Forecast
10.3.5 India Market Targeted Protein Degradation Drug Forecast
10.3.6 Australia Market Targeted Protein Degradation Drug Forecast
10.4 Europe Targeted Protein Degradation Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Targeted Protein Degradation Drug Forecast
10.4.2 France Market Targeted Protein Degradation Drug Forecast
10.4.3 UK Market Targeted Protein Degradation Drug Forecast
10.4.4 Italy Market Targeted Protein Degradation Drug Forecast
10.4.5 Russia Market Targeted Protein Degradation Drug Forecast
10.5 Middle East & Africa Targeted Protein Degradation Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Targeted Protein Degradation Drug Forecast
10.5.2 South Africa Market Targeted Protein Degradation Drug Forecast
10.5.3 Israel Market Targeted Protein Degradation Drug Forecast
10.5.4 Turkey Market Targeted Protein Degradation Drug Forecast
10.6 Global Targeted Protein Degradation Drug Forecast by Type (2027-2032)
10.7 Global Targeted Protein Degradation Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Targeted Protein Degradation Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Arvinas
11.1.1 Arvinas Company Information
11.1.2 Arvinas Targeted Protein Degradation Drug Product Offered
11.1.3 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Arvinas Main Business Overview
11.1.5 Arvinas Latest Developments
11.2 Kymera Therapeutics
11.2.1 Kymera Therapeutics Company Information
11.2.2 Kymera Therapeutics Targeted Protein Degradation Drug Product Offered
11.2.3 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Kymera Therapeutics Main Business Overview
11.2.5 Kymera Therapeutics Latest Developments
11.3 Dialectic Therapeutics
11.3.1 Dialectic Therapeutics Company Information
11.3.2 Dialectic Therapeutics Targeted Protein Degradation Drug Product Offered
11.3.3 Dialectic Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Dialectic Therapeutics Main Business Overview
11.3.5 Dialectic Therapeutics Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Targeted Protein Degradation Drug Product Offered
11.4.3 Bristol-Myers Squibb Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Nurix
11.5.1 Nurix Company Information
11.5.2 Nurix Targeted Protein Degradation Drug Product Offered
11.5.3 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Nurix Main Business Overview
11.5.5 Nurix Latest Developments
11.6 Cullgen
11.6.1 Cullgen Company Information
11.6.2 Cullgen Targeted Protein Degradation Drug Product Offered
11.6.3 Cullgen Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Cullgen Main Business Overview
11.6.5 Cullgen Latest Developments
11.7 C4 Therapeutics
11.7.1 C4 Therapeutics Company Information
11.7.2 C4 Therapeutics Targeted Protein Degradation Drug Product Offered
11.7.3 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 C4 Therapeutics Main Business Overview
11.7.5 C4 Therapeutics Latest Developments
11.8 Foghorn
11.8.1 Foghorn Company Information
11.8.2 Foghorn Targeted Protein Degradation Drug Product Offered
11.8.3 Foghorn Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Foghorn Main Business Overview
11.8.5 Foghorn Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Targeted Protein Degradation Drug Product Offered
11.9.3 Novartis Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Targeted Protein Degradation Drug Product Offered
11.10.3 Pfizer Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 MSD
11.11.1 MSD Company Information
11.11.2 MSD Targeted Protein Degradation Drug Product Offered
11.11.3 MSD Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 MSD Main Business Overview
11.11.5 MSD Latest Developments
11.12 Origami Therapeutics
11.12.1 Origami Therapeutics Company Information
11.12.2 Origami Therapeutics Targeted Protein Degradation Drug Product Offered
11.12.3 Origami Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Origami Therapeutics Main Business Overview
11.12.5 Origami Therapeutics Latest Developments
11.13 NEOsphere Biotechnologies
11.13.1 NEOsphere Biotechnologies Company Information
11.13.2 NEOsphere Biotechnologies Targeted Protein Degradation Drug Product Offered
11.13.3 NEOsphere Biotechnologies Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 NEOsphere Biotechnologies Main Business Overview
11.13.5 NEOsphere Biotechnologies Latest Developments
11.14 Dunad Therapeutics
11.14.1 Dunad Therapeutics Company Information
11.14.2 Dunad Therapeutics Targeted Protein Degradation Drug Product Offered
11.14.3 Dunad Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Dunad Therapeutics Main Business Overview
11.14.5 Dunad Therapeutics Latest Developments
11.15 Entact Bio
11.15.1 Entact Bio Company Information
11.15.2 Entact Bio Targeted Protein Degradation Drug Product Offered
11.15.3 Entact Bio Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Entact Bio Main Business Overview
11.15.5 Entact Bio Latest Developments
11.16 Proxygen
11.16.1 Proxygen Company Information
11.16.2 Proxygen Targeted Protein Degradation Drug Product Offered
11.16.3 Proxygen Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Proxygen Main Business Overview
11.16.5 Proxygen Latest Developments
11.17 Monte Rosa Therapeutics
11.17.1 Monte Rosa Therapeutics Company Information
11.17.2 Monte Rosa Therapeutics Targeted Protein Degradation Drug Product Offered
11.17.3 Monte Rosa Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Monte Rosa Therapeutics Main Business Overview
11.17.5 Monte Rosa Therapeutics Latest Developments
11.18 Treeline Biosciences
11.18.1 Treeline Biosciences Company Information
11.18.2 Treeline Biosciences Targeted Protein Degradation Drug Product Offered
11.18.3 Treeline Biosciences Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Treeline Biosciences Main Business Overview
11.18.5 Treeline Biosciences Latest Developments
11.19 Ubiquigent
11.19.1 Ubiquigent Company Information
11.19.2 Ubiquigent Targeted Protein Degradation Drug Product Offered
11.19.3 Ubiquigent Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Ubiquigent Main Business Overview
11.19.5 Ubiquigent Latest Developments
11.20 Kangpu Biopharmaceuticals
11.20.1 Kangpu Biopharmaceuticals Company Information
11.20.2 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product Offered
11.20.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Kangpu Biopharmaceuticals Main Business Overview
11.20.5 Kangpu Biopharmaceuticals Latest Developments
11.21 Ranok Therapeutics
11.21.1 Ranok Therapeutics Company Information
11.21.2 Ranok Therapeutics Targeted Protein Degradation Drug Product Offered
11.21.3 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Ranok Therapeutics Main Business Overview
11.21.5 Ranok Therapeutics Latest Developments
11.22 Accutar Biotech
11.22.1 Accutar Biotech Company Information
11.22.2 Accutar Biotech Targeted Protein Degradation Drug Product Offered
11.22.3 Accutar Biotech Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Accutar Biotech Main Business Overview
11.22.5 Accutar Biotech Latest Developments
11.23 BeiGene
11.23.1 BeiGene Company Information
11.23.2 BeiGene Targeted Protein Degradation Drug Product Offered
11.23.3 BeiGene Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 BeiGene Main Business Overview
11.23.5 BeiGene Latest Developments
11.24 Hinova Pharma
11.24.1 Hinova Pharma Company Information
11.24.2 Hinova Pharma Targeted Protein Degradation Drug Product Offered
11.24.3 Hinova Pharma Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Hinova Pharma Main Business Overview
11.24.5 Hinova Pharma Latest Developments
11.25 Haisco Pharmaceutical
11.25.1 Haisco Pharmaceutical Company Information
11.25.2 Haisco Pharmaceutical Targeted Protein Degradation Drug Product Offered
11.25.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Haisco Pharmaceutical Main Business Overview
11.25.5 Haisco Pharmaceutical Latest Developments
11.26 CTTQ
11.26.1 CTTQ Company Information
11.26.2 CTTQ Targeted Protein Degradation Drug Product Offered
11.26.3 CTTQ Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 CTTQ Main Business Overview
11.26.5 CTTQ Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Protein Degradation Drug Market Size (2021-2032)
2.1.2 Targeted Protein Degradation Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Targeted Protein Degradation Drug by Country/Region (2021, 2025 & 2032)
2.2 Targeted Protein Degradation Drug Segment by Type
2.2.1 PROTAC
2.2.2 Molecular Glues
2.2.3 Other Ubiquitin-Proteasome System Technologies
2.2.4 Lysosomal System Technologies
2.2.5 Targeted Protein Degradation Drug Market Size by Type
2.2.5.1 Targeted Protein Degradation Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
2.3 Targeted Protein Degradation Drug Segment by Degradation Pathway
2.3.1 Proteasome-mediated Degradation
2.3.2 Lysosome-mediated Degradation
2.3.3 Autophagy-mediated Degradation
2.3.4 Targeted Protein Degradation Drug Market Size by Degradation Pathway
2.3.4.1 Targeted Protein Degradation Drug Market Size CAGR by Degradation Pathway (2021 VS 2025 VS 2032)
2.3.4.2 Global Targeted Protein Degradation Drug Market Size Market Share by Degradation Pathway (2021-2026)
2.4 Targeted Protein Degradation Drug Segment by Molecular Structure
2.4.1 Small-molecule Degraders
2.4.2 Biologics-based Degraders
2.4.3 Oligonucleotide / RNA-targeting Degraders
2.4.4 Targeted Protein Degradation Drug Market Size by Molecular Structure
2.4.4.1 Targeted Protein Degradation Drug Market Size CAGR by Molecular Structure (2021 VS 2025 VS 2032)
2.4.4.2 Global Targeted Protein Degradation Drug Market Size Market Share by Molecular Structure (2021-2026)
2.5 Targeted Protein Degradation Drug Segment by Application
2.5.1 Prostate Cancer
2.5.2 Breast Cancer
2.5.3 Lymphoma
2.5.4 Others
2.5.5 Targeted Protein Degradation Drug Market Size by Application
2.5.5.1 Targeted Protein Degradation Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
3 TARGETED PROTEIN DEGRADATION DRUG MARKET SIZE BY PLAYER
3.1 Targeted Protein Degradation Drug Market Size Market Share by Player
3.1.1 Global Targeted Protein Degradation Drug Revenue by Player (2021-2026)
3.1.2 Global Targeted Protein Degradation Drug Revenue Market Share by Player (2021-2026)
3.2 Global Targeted Protein Degradation Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED PROTEIN DEGRADATION DRUG BY REGION
4.1 Targeted Protein Degradation Drug Market Size by Region (2021-2026)
4.2 Global Targeted Protein Degradation Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Targeted Protein Degradation Drug Market Size Growth (2021-2026)
4.4 APAC Targeted Protein Degradation Drug Market Size Growth (2021-2026)
4.5 Europe Targeted Protein Degradation Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Targeted Protein Degradation Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Targeted Protein Degradation Drug Market Size by Country (2021-2026)
5.2 Americas Targeted Protein Degradation Drug Market Size by Type (2021-2026)
5.3 Americas Targeted Protein Degradation Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Protein Degradation Drug Market Size by Region (2021-2026)
6.2 APAC Targeted Protein Degradation Drug Market Size by Type (2021-2026)
6.3 APAC Targeted Protein Degradation Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Protein Degradation Drug Market Size by Country (2021-2026)
7.2 Europe Targeted Protein Degradation Drug Market Size by Type (2021-2026)
7.3 Europe Targeted Protein Degradation Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Protein Degradation Drug by Region (2021-2026)
8.2 Middle East & Africa Targeted Protein Degradation Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Targeted Protein Degradation Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED PROTEIN DEGRADATION DRUG MARKET FORECAST
10.1 Global Targeted Protein Degradation Drug Forecast by Region (2027-2032)
10.1.1 Global Targeted Protein Degradation Drug Forecast by Region (2027-2032)
10.1.2 Americas Targeted Protein Degradation Drug Forecast
10.1.3 APAC Targeted Protein Degradation Drug Forecast
10.1.4 Europe Targeted Protein Degradation Drug Forecast
10.1.5 Middle East & Africa Targeted Protein Degradation Drug Forecast
10.2 Americas Targeted Protein Degradation Drug Forecast by Country (2027-2032)
10.2.1 United States Market Targeted Protein Degradation Drug Forecast
10.2.2 Canada Market Targeted Protein Degradation Drug Forecast
10.2.3 Mexico Market Targeted Protein Degradation Drug Forecast
10.2.4 Brazil Market Targeted Protein Degradation Drug Forecast
10.3 APAC Targeted Protein Degradation Drug Forecast by Region (2027-2032)
10.3.1 China Targeted Protein Degradation Drug Market Forecast
10.3.2 Japan Market Targeted Protein Degradation Drug Forecast
10.3.3 Korea Market Targeted Protein Degradation Drug Forecast
10.3.4 Southeast Asia Market Targeted Protein Degradation Drug Forecast
10.3.5 India Market Targeted Protein Degradation Drug Forecast
10.3.6 Australia Market Targeted Protein Degradation Drug Forecast
10.4 Europe Targeted Protein Degradation Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Targeted Protein Degradation Drug Forecast
10.4.2 France Market Targeted Protein Degradation Drug Forecast
10.4.3 UK Market Targeted Protein Degradation Drug Forecast
10.4.4 Italy Market Targeted Protein Degradation Drug Forecast
10.4.5 Russia Market Targeted Protein Degradation Drug Forecast
10.5 Middle East & Africa Targeted Protein Degradation Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Targeted Protein Degradation Drug Forecast
10.5.2 South Africa Market Targeted Protein Degradation Drug Forecast
10.5.3 Israel Market Targeted Protein Degradation Drug Forecast
10.5.4 Turkey Market Targeted Protein Degradation Drug Forecast
10.6 Global Targeted Protein Degradation Drug Forecast by Type (2027-2032)
10.7 Global Targeted Protein Degradation Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Targeted Protein Degradation Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Arvinas
11.1.1 Arvinas Company Information
11.1.2 Arvinas Targeted Protein Degradation Drug Product Offered
11.1.3 Arvinas Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Arvinas Main Business Overview
11.1.5 Arvinas Latest Developments
11.2 Kymera Therapeutics
11.2.1 Kymera Therapeutics Company Information
11.2.2 Kymera Therapeutics Targeted Protein Degradation Drug Product Offered
11.2.3 Kymera Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Kymera Therapeutics Main Business Overview
11.2.5 Kymera Therapeutics Latest Developments
11.3 Dialectic Therapeutics
11.3.1 Dialectic Therapeutics Company Information
11.3.2 Dialectic Therapeutics Targeted Protein Degradation Drug Product Offered
11.3.3 Dialectic Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Dialectic Therapeutics Main Business Overview
11.3.5 Dialectic Therapeutics Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Targeted Protein Degradation Drug Product Offered
11.4.3 Bristol-Myers Squibb Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Nurix
11.5.1 Nurix Company Information
11.5.2 Nurix Targeted Protein Degradation Drug Product Offered
11.5.3 Nurix Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Nurix Main Business Overview
11.5.5 Nurix Latest Developments
11.6 Cullgen
11.6.1 Cullgen Company Information
11.6.2 Cullgen Targeted Protein Degradation Drug Product Offered
11.6.3 Cullgen Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Cullgen Main Business Overview
11.6.5 Cullgen Latest Developments
11.7 C4 Therapeutics
11.7.1 C4 Therapeutics Company Information
11.7.2 C4 Therapeutics Targeted Protein Degradation Drug Product Offered
11.7.3 C4 Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 C4 Therapeutics Main Business Overview
11.7.5 C4 Therapeutics Latest Developments
11.8 Foghorn
11.8.1 Foghorn Company Information
11.8.2 Foghorn Targeted Protein Degradation Drug Product Offered
11.8.3 Foghorn Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Foghorn Main Business Overview
11.8.5 Foghorn Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Targeted Protein Degradation Drug Product Offered
11.9.3 Novartis Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Targeted Protein Degradation Drug Product Offered
11.10.3 Pfizer Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 MSD
11.11.1 MSD Company Information
11.11.2 MSD Targeted Protein Degradation Drug Product Offered
11.11.3 MSD Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 MSD Main Business Overview
11.11.5 MSD Latest Developments
11.12 Origami Therapeutics
11.12.1 Origami Therapeutics Company Information
11.12.2 Origami Therapeutics Targeted Protein Degradation Drug Product Offered
11.12.3 Origami Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Origami Therapeutics Main Business Overview
11.12.5 Origami Therapeutics Latest Developments
11.13 NEOsphere Biotechnologies
11.13.1 NEOsphere Biotechnologies Company Information
11.13.2 NEOsphere Biotechnologies Targeted Protein Degradation Drug Product Offered
11.13.3 NEOsphere Biotechnologies Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 NEOsphere Biotechnologies Main Business Overview
11.13.5 NEOsphere Biotechnologies Latest Developments
11.14 Dunad Therapeutics
11.14.1 Dunad Therapeutics Company Information
11.14.2 Dunad Therapeutics Targeted Protein Degradation Drug Product Offered
11.14.3 Dunad Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Dunad Therapeutics Main Business Overview
11.14.5 Dunad Therapeutics Latest Developments
11.15 Entact Bio
11.15.1 Entact Bio Company Information
11.15.2 Entact Bio Targeted Protein Degradation Drug Product Offered
11.15.3 Entact Bio Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Entact Bio Main Business Overview
11.15.5 Entact Bio Latest Developments
11.16 Proxygen
11.16.1 Proxygen Company Information
11.16.2 Proxygen Targeted Protein Degradation Drug Product Offered
11.16.3 Proxygen Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Proxygen Main Business Overview
11.16.5 Proxygen Latest Developments
11.17 Monte Rosa Therapeutics
11.17.1 Monte Rosa Therapeutics Company Information
11.17.2 Monte Rosa Therapeutics Targeted Protein Degradation Drug Product Offered
11.17.3 Monte Rosa Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Monte Rosa Therapeutics Main Business Overview
11.17.5 Monte Rosa Therapeutics Latest Developments
11.18 Treeline Biosciences
11.18.1 Treeline Biosciences Company Information
11.18.2 Treeline Biosciences Targeted Protein Degradation Drug Product Offered
11.18.3 Treeline Biosciences Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Treeline Biosciences Main Business Overview
11.18.5 Treeline Biosciences Latest Developments
11.19 Ubiquigent
11.19.1 Ubiquigent Company Information
11.19.2 Ubiquigent Targeted Protein Degradation Drug Product Offered
11.19.3 Ubiquigent Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Ubiquigent Main Business Overview
11.19.5 Ubiquigent Latest Developments
11.20 Kangpu Biopharmaceuticals
11.20.1 Kangpu Biopharmaceuticals Company Information
11.20.2 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product Offered
11.20.3 Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Kangpu Biopharmaceuticals Main Business Overview
11.20.5 Kangpu Biopharmaceuticals Latest Developments
11.21 Ranok Therapeutics
11.21.1 Ranok Therapeutics Company Information
11.21.2 Ranok Therapeutics Targeted Protein Degradation Drug Product Offered
11.21.3 Ranok Therapeutics Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Ranok Therapeutics Main Business Overview
11.21.5 Ranok Therapeutics Latest Developments
11.22 Accutar Biotech
11.22.1 Accutar Biotech Company Information
11.22.2 Accutar Biotech Targeted Protein Degradation Drug Product Offered
11.22.3 Accutar Biotech Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Accutar Biotech Main Business Overview
11.22.5 Accutar Biotech Latest Developments
11.23 BeiGene
11.23.1 BeiGene Company Information
11.23.2 BeiGene Targeted Protein Degradation Drug Product Offered
11.23.3 BeiGene Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 BeiGene Main Business Overview
11.23.5 BeiGene Latest Developments
11.24 Hinova Pharma
11.24.1 Hinova Pharma Company Information
11.24.2 Hinova Pharma Targeted Protein Degradation Drug Product Offered
11.24.3 Hinova Pharma Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Hinova Pharma Main Business Overview
11.24.5 Hinova Pharma Latest Developments
11.25 Haisco Pharmaceutical
11.25.1 Haisco Pharmaceutical Company Information
11.25.2 Haisco Pharmaceutical Targeted Protein Degradation Drug Product Offered
11.25.3 Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.25.4 Haisco Pharmaceutical Main Business Overview
11.25.5 Haisco Pharmaceutical Latest Developments
11.26 CTTQ
11.26.1 CTTQ Company Information
11.26.2 CTTQ Targeted Protein Degradation Drug Product Offered
11.26.3 CTTQ Targeted Protein Degradation Drug Revenue, Gross Margin and Market Share (2021-2026)
11.26.4 CTTQ Main Business Overview
11.26.5 CTTQ Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Protein Degradation Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Targeted Protein Degradation Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of PROTAC
Table 4. Major Players of Molecular Glues
Table 5. Major Players of Other Ubiquitin-Proteasome System Technologies
Table 6. Major Players of Lysosomal System Technologies
Table 7. Targeted Protein Degradation Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Targeted Protein Degradation Drug Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Proteasome-mediated Degradation
Table 11. Major Players of Lysosome-mediated Degradation
Table 12. Major Players of Autophagy-mediated Degradation
Table 13. Targeted Protein Degradation Drug Market Size CAGR by Degradation Pathway (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Targeted Protein Degradation Drug Market Size by Degradation Pathway (2021-2026) & ($ millions)
Table 15. Global Targeted Protein Degradation Drug Market Size Market Share by Degradation Pathway (2021-2026)
Table 16. Major Players of Small-molecule Degraders
Table 17. Major Players of Biologics-based Degraders
Table 18. Major Players of Oligonucleotide / RNA-targeting Degraders
Table 19. Targeted Protein Degradation Drug Market Size CAGR by Molecular Structure (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Targeted Protein Degradation Drug Market Size by Molecular Structure (2021-2026) & ($ millions)
Table 21. Global Targeted Protein Degradation Drug Market Size Market Share by Molecular Structure (2021-2026)
Table 22. Targeted Protein Degradation Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Targeted Protein Degradation Drug Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
Table 25. Global Targeted Protein Degradation Drug Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Targeted Protein Degradation Drug Revenue Market Share by Player (2021-2026)
Table 27. Targeted Protein Degradation Drug Key Players Head office and Products Offered
Table 28. Targeted Protein Degradation Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Targeted Protein Degradation Drug Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Targeted Protein Degradation Drug Market Size Market Share by Region (2021-2026)
Table 33. Global Targeted Protein Degradation Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Targeted Protein Degradation Drug Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Targeted Protein Degradation Drug Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Targeted Protein Degradation Drug Market Size Market Share by Country (2021-2026)
Table 37. Americas Targeted Protein Degradation Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
Table 39. Americas Targeted Protein Degradation Drug Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
Table 41. APAC Targeted Protein Degradation Drug Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Targeted Protein Degradation Drug Market Size Market Share by Region (2021-2026)
Table 43. APAC Targeted Protein Degradation Drug Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Targeted Protein Degradation Drug Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Targeted Protein Degradation Drug Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Targeted Protein Degradation Drug Market Size Market Share by Country (2021-2026)
Table 47. Europe Targeted Protein Degradation Drug Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Targeted Protein Degradation Drug Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Targeted Protein Degradation Drug Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Targeted Protein Degradation Drug Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Targeted Protein Degradation Drug Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Targeted Protein Degradation Drug
Table 53. Key Market Challenges & Risks of Targeted Protein Degradation Drug
Table 54. Key Industry Trends of Targeted Protein Degradation Drug
Table 55. Global Targeted Protein Degradation Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Targeted Protein Degradation Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Targeted Protein Degradation Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Arvinas Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 60. Arvinas Targeted Protein Degradation Drug Product Offered
Table 61. Arvinas Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Arvinas Main Business
Table 63. Arvinas Latest Developments
Table 64. Kymera Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 65. Kymera Therapeutics Targeted Protein Degradation Drug Product Offered
Table 66. Kymera Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Kymera Therapeutics Main Business
Table 68. Kymera Therapeutics Latest Developments
Table 69. Dialectic Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 70. Dialectic Therapeutics Targeted Protein Degradation Drug Product Offered
Table 71. Dialectic Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Dialectic Therapeutics Main Business
Table 73. Dialectic Therapeutics Latest Developments
Table 74. Bristol-Myers Squibb Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 75. Bristol-Myers Squibb Targeted Protein Degradation Drug Product Offered
Table 76. Bristol-Myers Squibb Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Bristol-Myers Squibb Main Business
Table 78. Bristol-Myers Squibb Latest Developments
Table 79. Nurix Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 80. Nurix Targeted Protein Degradation Drug Product Offered
Table 81. Nurix Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Nurix Main Business
Table 83. Nurix Latest Developments
Table 84. Cullgen Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 85. Cullgen Targeted Protein Degradation Drug Product Offered
Table 86. Cullgen Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Cullgen Main Business
Table 88. Cullgen Latest Developments
Table 89. C4 Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 90. C4 Therapeutics Targeted Protein Degradation Drug Product Offered
Table 91. C4 Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. C4 Therapeutics Main Business
Table 93. C4 Therapeutics Latest Developments
Table 94. Foghorn Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 95. Foghorn Targeted Protein Degradation Drug Product Offered
Table 96. Foghorn Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Foghorn Main Business
Table 98. Foghorn Latest Developments
Table 99. Novartis Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 100. Novartis Targeted Protein Degradation Drug Product Offered
Table 101. Novartis Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Novartis Main Business
Table 103. Novartis Latest Developments
Table 104. Pfizer Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 105. Pfizer Targeted Protein Degradation Drug Product Offered
Table 106. Pfizer Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. MSD Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 110. MSD Targeted Protein Degradation Drug Product Offered
Table 111. MSD Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. MSD Main Business
Table 113. MSD Latest Developments
Table 114. Origami Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 115. Origami Therapeutics Targeted Protein Degradation Drug Product Offered
Table 116. Origami Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Origami Therapeutics Main Business
Table 118. Origami Therapeutics Latest Developments
Table 119. NEOsphere Biotechnologies Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 120. NEOsphere Biotechnologies Targeted Protein Degradation Drug Product Offered
Table 121. NEOsphere Biotechnologies Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. NEOsphere Biotechnologies Main Business
Table 123. NEOsphere Biotechnologies Latest Developments
Table 124. Dunad Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 125. Dunad Therapeutics Targeted Protein Degradation Drug Product Offered
Table 126. Dunad Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Dunad Therapeutics Main Business
Table 128. Dunad Therapeutics Latest Developments
Table 129. Entact Bio Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 130. Entact Bio Targeted Protein Degradation Drug Product Offered
Table 131. Entact Bio Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Entact Bio Main Business
Table 133. Entact Bio Latest Developments
Table 134. Proxygen Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 135. Proxygen Targeted Protein Degradation Drug Product Offered
Table 136. Proxygen Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Proxygen Main Business
Table 138. Proxygen Latest Developments
Table 139. Monte Rosa Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 140. Monte Rosa Therapeutics Targeted Protein Degradation Drug Product Offered
Table 141. Monte Rosa Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Monte Rosa Therapeutics Main Business
Table 143. Monte Rosa Therapeutics Latest Developments
Table 144. Treeline Biosciences Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 145. Treeline Biosciences Targeted Protein Degradation Drug Product Offered
Table 146. Treeline Biosciences Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Treeline Biosciences Main Business
Table 148. Treeline Biosciences Latest Developments
Table 149. Ubiquigent Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 150. Ubiquigent Targeted Protein Degradation Drug Product Offered
Table 151. Ubiquigent Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Ubiquigent Main Business
Table 153. Ubiquigent Latest Developments
Table 154. Kangpu Biopharmaceuticals Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 155. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product Offered
Table 156. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. Kangpu Biopharmaceuticals Main Business
Table 158. Kangpu Biopharmaceuticals Latest Developments
Table 159. Ranok Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 160. Ranok Therapeutics Targeted Protein Degradation Drug Product Offered
Table 161. Ranok Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 162. Ranok Therapeutics Main Business
Table 163. Ranok Therapeutics Latest Developments
Table 164. Accutar Biotech Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 165. Accutar Biotech Targeted Protein Degradation Drug Product Offered
Table 166. Accutar Biotech Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 167. Accutar Biotech Main Business
Table 168. Accutar Biotech Latest Developments
Table 169. BeiGene Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 170. BeiGene Targeted Protein Degradation Drug Product Offered
Table 171. BeiGene Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 172. BeiGene Main Business
Table 173. BeiGene Latest Developments
Table 174. Hinova Pharma Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 175. Hinova Pharma Targeted Protein Degradation Drug Product Offered
Table 176. Hinova Pharma Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 177. Hinova Pharma Main Business
Table 178. Hinova Pharma Latest Developments
Table 179. Haisco Pharmaceutical Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 180. Haisco Pharmaceutical Targeted Protein Degradation Drug Product Offered
Table 181. Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 182. Haisco Pharmaceutical Main Business
Table 183. Haisco Pharmaceutical Latest Developments
Table 184. CTTQ Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 185. CTTQ Targeted Protein Degradation Drug Product Offered
Table 186. CTTQ Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 187. CTTQ Main Business
Table 188. CTTQ Latest Developments
Table 1. Targeted Protein Degradation Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Targeted Protein Degradation Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of PROTAC
Table 4. Major Players of Molecular Glues
Table 5. Major Players of Other Ubiquitin-Proteasome System Technologies
Table 6. Major Players of Lysosomal System Technologies
Table 7. Targeted Protein Degradation Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Targeted Protein Degradation Drug Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Proteasome-mediated Degradation
Table 11. Major Players of Lysosome-mediated Degradation
Table 12. Major Players of Autophagy-mediated Degradation
Table 13. Targeted Protein Degradation Drug Market Size CAGR by Degradation Pathway (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Targeted Protein Degradation Drug Market Size by Degradation Pathway (2021-2026) & ($ millions)
Table 15. Global Targeted Protein Degradation Drug Market Size Market Share by Degradation Pathway (2021-2026)
Table 16. Major Players of Small-molecule Degraders
Table 17. Major Players of Biologics-based Degraders
Table 18. Major Players of Oligonucleotide / RNA-targeting Degraders
Table 19. Targeted Protein Degradation Drug Market Size CAGR by Molecular Structure (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Targeted Protein Degradation Drug Market Size by Molecular Structure (2021-2026) & ($ millions)
Table 21. Global Targeted Protein Degradation Drug Market Size Market Share by Molecular Structure (2021-2026)
Table 22. Targeted Protein Degradation Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Targeted Protein Degradation Drug Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
Table 25. Global Targeted Protein Degradation Drug Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Targeted Protein Degradation Drug Revenue Market Share by Player (2021-2026)
Table 27. Targeted Protein Degradation Drug Key Players Head office and Products Offered
Table 28. Targeted Protein Degradation Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Targeted Protein Degradation Drug Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Targeted Protein Degradation Drug Market Size Market Share by Region (2021-2026)
Table 33. Global Targeted Protein Degradation Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Targeted Protein Degradation Drug Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Targeted Protein Degradation Drug Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Targeted Protein Degradation Drug Market Size Market Share by Country (2021-2026)
Table 37. Americas Targeted Protein Degradation Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
Table 39. Americas Targeted Protein Degradation Drug Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
Table 41. APAC Targeted Protein Degradation Drug Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Targeted Protein Degradation Drug Market Size Market Share by Region (2021-2026)
Table 43. APAC Targeted Protein Degradation Drug Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Targeted Protein Degradation Drug Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Targeted Protein Degradation Drug Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Targeted Protein Degradation Drug Market Size Market Share by Country (2021-2026)
Table 47. Europe Targeted Protein Degradation Drug Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Targeted Protein Degradation Drug Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Targeted Protein Degradation Drug Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Targeted Protein Degradation Drug Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Targeted Protein Degradation Drug Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Targeted Protein Degradation Drug
Table 53. Key Market Challenges & Risks of Targeted Protein Degradation Drug
Table 54. Key Industry Trends of Targeted Protein Degradation Drug
Table 55. Global Targeted Protein Degradation Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Targeted Protein Degradation Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Targeted Protein Degradation Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Arvinas Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 60. Arvinas Targeted Protein Degradation Drug Product Offered
Table 61. Arvinas Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Arvinas Main Business
Table 63. Arvinas Latest Developments
Table 64. Kymera Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 65. Kymera Therapeutics Targeted Protein Degradation Drug Product Offered
Table 66. Kymera Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Kymera Therapeutics Main Business
Table 68. Kymera Therapeutics Latest Developments
Table 69. Dialectic Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 70. Dialectic Therapeutics Targeted Protein Degradation Drug Product Offered
Table 71. Dialectic Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Dialectic Therapeutics Main Business
Table 73. Dialectic Therapeutics Latest Developments
Table 74. Bristol-Myers Squibb Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 75. Bristol-Myers Squibb Targeted Protein Degradation Drug Product Offered
Table 76. Bristol-Myers Squibb Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Bristol-Myers Squibb Main Business
Table 78. Bristol-Myers Squibb Latest Developments
Table 79. Nurix Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 80. Nurix Targeted Protein Degradation Drug Product Offered
Table 81. Nurix Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Nurix Main Business
Table 83. Nurix Latest Developments
Table 84. Cullgen Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 85. Cullgen Targeted Protein Degradation Drug Product Offered
Table 86. Cullgen Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Cullgen Main Business
Table 88. Cullgen Latest Developments
Table 89. C4 Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 90. C4 Therapeutics Targeted Protein Degradation Drug Product Offered
Table 91. C4 Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. C4 Therapeutics Main Business
Table 93. C4 Therapeutics Latest Developments
Table 94. Foghorn Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 95. Foghorn Targeted Protein Degradation Drug Product Offered
Table 96. Foghorn Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. Foghorn Main Business
Table 98. Foghorn Latest Developments
Table 99. Novartis Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 100. Novartis Targeted Protein Degradation Drug Product Offered
Table 101. Novartis Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Novartis Main Business
Table 103. Novartis Latest Developments
Table 104. Pfizer Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 105. Pfizer Targeted Protein Degradation Drug Product Offered
Table 106. Pfizer Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. MSD Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 110. MSD Targeted Protein Degradation Drug Product Offered
Table 111. MSD Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. MSD Main Business
Table 113. MSD Latest Developments
Table 114. Origami Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 115. Origami Therapeutics Targeted Protein Degradation Drug Product Offered
Table 116. Origami Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Origami Therapeutics Main Business
Table 118. Origami Therapeutics Latest Developments
Table 119. NEOsphere Biotechnologies Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 120. NEOsphere Biotechnologies Targeted Protein Degradation Drug Product Offered
Table 121. NEOsphere Biotechnologies Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. NEOsphere Biotechnologies Main Business
Table 123. NEOsphere Biotechnologies Latest Developments
Table 124. Dunad Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 125. Dunad Therapeutics Targeted Protein Degradation Drug Product Offered
Table 126. Dunad Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Dunad Therapeutics Main Business
Table 128. Dunad Therapeutics Latest Developments
Table 129. Entact Bio Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 130. Entact Bio Targeted Protein Degradation Drug Product Offered
Table 131. Entact Bio Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Entact Bio Main Business
Table 133. Entact Bio Latest Developments
Table 134. Proxygen Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 135. Proxygen Targeted Protein Degradation Drug Product Offered
Table 136. Proxygen Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Proxygen Main Business
Table 138. Proxygen Latest Developments
Table 139. Monte Rosa Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 140. Monte Rosa Therapeutics Targeted Protein Degradation Drug Product Offered
Table 141. Monte Rosa Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Monte Rosa Therapeutics Main Business
Table 143. Monte Rosa Therapeutics Latest Developments
Table 144. Treeline Biosciences Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 145. Treeline Biosciences Targeted Protein Degradation Drug Product Offered
Table 146. Treeline Biosciences Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Treeline Biosciences Main Business
Table 148. Treeline Biosciences Latest Developments
Table 149. Ubiquigent Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 150. Ubiquigent Targeted Protein Degradation Drug Product Offered
Table 151. Ubiquigent Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Ubiquigent Main Business
Table 153. Ubiquigent Latest Developments
Table 154. Kangpu Biopharmaceuticals Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 155. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Product Offered
Table 156. Kangpu Biopharmaceuticals Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. Kangpu Biopharmaceuticals Main Business
Table 158. Kangpu Biopharmaceuticals Latest Developments
Table 159. Ranok Therapeutics Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 160. Ranok Therapeutics Targeted Protein Degradation Drug Product Offered
Table 161. Ranok Therapeutics Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 162. Ranok Therapeutics Main Business
Table 163. Ranok Therapeutics Latest Developments
Table 164. Accutar Biotech Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 165. Accutar Biotech Targeted Protein Degradation Drug Product Offered
Table 166. Accutar Biotech Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 167. Accutar Biotech Main Business
Table 168. Accutar Biotech Latest Developments
Table 169. BeiGene Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 170. BeiGene Targeted Protein Degradation Drug Product Offered
Table 171. BeiGene Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 172. BeiGene Main Business
Table 173. BeiGene Latest Developments
Table 174. Hinova Pharma Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 175. Hinova Pharma Targeted Protein Degradation Drug Product Offered
Table 176. Hinova Pharma Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 177. Hinova Pharma Main Business
Table 178. Hinova Pharma Latest Developments
Table 179. Haisco Pharmaceutical Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 180. Haisco Pharmaceutical Targeted Protein Degradation Drug Product Offered
Table 181. Haisco Pharmaceutical Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 182. Haisco Pharmaceutical Main Business
Table 183. Haisco Pharmaceutical Latest Developments
Table 184. CTTQ Details, Company Type, Targeted Protein Degradation Drug Area Served and Its Competitors
Table 185. CTTQ Targeted Protein Degradation Drug Product Offered
Table 186. CTTQ Targeted Protein Degradation Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 187. CTTQ Main Business
Table 188. CTTQ Latest Developments
LIST OF FIGURES
Figure 1. Targeted Protein Degradation Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Protein Degradation Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Targeted Protein Degradation Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Targeted Protein Degradation Drug Sales Market Share by Country/Region (2025)
Figure 8. Targeted Protein Degradation Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Targeted Protein Degradation Drug Market Size Market Share by Type in 2025
Figure 10. Global Targeted Protein Degradation Drug Market Size Market Share by Degradation Pathway in 2025
Figure 11. Global Targeted Protein Degradation Drug Market Size Market Share by Molecular Structure in 2025
Figure 12. Targeted Protein Degradation Drug in Prostate Cancer
Figure 13. Global Targeted Protein Degradation Drug Market: Prostate Cancer (2021-2026) & ($ millions)
Figure 14. Targeted Protein Degradation Drug in Breast Cancer
Figure 15. Global Targeted Protein Degradation Drug Market: Breast Cancer (2021-2026) & ($ millions)
Figure 16. Targeted Protein Degradation Drug in Lymphoma
Figure 17. Global Targeted Protein Degradation Drug Market: Lymphoma (2021-2026) & ($ millions)
Figure 18. Targeted Protein Degradation Drug in Others
Figure 19. Global Targeted Protein Degradation Drug Market: Others (2021-2026) & ($ millions)
Figure 20. Global Targeted Protein Degradation Drug Market Size Market Share by Application in 2025
Figure 21. Global Targeted Protein Degradation Drug Revenue Market Share by Player in 2025
Figure 22. Global Targeted Protein Degradation Drug Market Size Market Share by Region (2021-2026)
Figure 23. Americas Targeted Protein Degradation Drug Market Size 2021-2026 ($ millions)
Figure 24. APAC Targeted Protein Degradation Drug Market Size 2021-2026 ($ millions)
Figure 25. Europe Targeted Protein Degradation Drug Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Targeted Protein Degradation Drug Market Size 2021-2026 ($ millions)
Figure 27. Americas Targeted Protein Degradation Drug Value Market Share by Country in 2025
Figure 28. United States Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Targeted Protein Degradation Drug Market Size Market Share by Region in 2025
Figure 33. APAC Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
Figure 34. APAC Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
Figure 35. China Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. India Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Targeted Protein Degradation Drug Market Size Market Share by Country in 2025
Figure 42. Europe Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
Figure 43. Europe Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
Figure 44. Germany Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. France Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 58. APAC Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 59. Europe Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 61. United States Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 62. Canada Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 63. Mexico Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 64. Brazil Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 65. China Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 66. Japan Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 67. Korea Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 69. India Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 70. Australia Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 71. Germany Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 72. France Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 73. UK Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 74. Italy Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 75. Russia Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 76. Egypt Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 77. South Africa Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 78. Israel Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 79. Turkey Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 80. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 1. Targeted Protein Degradation Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Protein Degradation Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Targeted Protein Degradation Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Targeted Protein Degradation Drug Sales Market Share by Country/Region (2025)
Figure 8. Targeted Protein Degradation Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Targeted Protein Degradation Drug Market Size Market Share by Type in 2025
Figure 10. Global Targeted Protein Degradation Drug Market Size Market Share by Degradation Pathway in 2025
Figure 11. Global Targeted Protein Degradation Drug Market Size Market Share by Molecular Structure in 2025
Figure 12. Targeted Protein Degradation Drug in Prostate Cancer
Figure 13. Global Targeted Protein Degradation Drug Market: Prostate Cancer (2021-2026) & ($ millions)
Figure 14. Targeted Protein Degradation Drug in Breast Cancer
Figure 15. Global Targeted Protein Degradation Drug Market: Breast Cancer (2021-2026) & ($ millions)
Figure 16. Targeted Protein Degradation Drug in Lymphoma
Figure 17. Global Targeted Protein Degradation Drug Market: Lymphoma (2021-2026) & ($ millions)
Figure 18. Targeted Protein Degradation Drug in Others
Figure 19. Global Targeted Protein Degradation Drug Market: Others (2021-2026) & ($ millions)
Figure 20. Global Targeted Protein Degradation Drug Market Size Market Share by Application in 2025
Figure 21. Global Targeted Protein Degradation Drug Revenue Market Share by Player in 2025
Figure 22. Global Targeted Protein Degradation Drug Market Size Market Share by Region (2021-2026)
Figure 23. Americas Targeted Protein Degradation Drug Market Size 2021-2026 ($ millions)
Figure 24. APAC Targeted Protein Degradation Drug Market Size 2021-2026 ($ millions)
Figure 25. Europe Targeted Protein Degradation Drug Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Targeted Protein Degradation Drug Market Size 2021-2026 ($ millions)
Figure 27. Americas Targeted Protein Degradation Drug Value Market Share by Country in 2025
Figure 28. United States Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Targeted Protein Degradation Drug Market Size Market Share by Region in 2025
Figure 33. APAC Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
Figure 34. APAC Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
Figure 35. China Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 39. India Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Targeted Protein Degradation Drug Market Size Market Share by Country in 2025
Figure 42. Europe Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
Figure 43. Europe Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
Figure 44. Germany Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. France Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Targeted Protein Degradation Drug Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Targeted Protein Degradation Drug Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 58. APAC Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 59. Europe Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 61. United States Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 62. Canada Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 63. Mexico Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 64. Brazil Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 65. China Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 66. Japan Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 67. Korea Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 69. India Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 70. Australia Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 71. Germany Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 72. France Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 73. UK Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 74. Italy Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 75. Russia Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 76. Egypt Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 77. South Africa Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 78. Israel Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 79. Turkey Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
Figure 80. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Targeted Protein Degradation Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Targeted Protein Degradation Drug Market Size 2027-2032 ($ millions)
